Edwards Lifesciences (EW) PT Raised to $93 at Piper Sandler Following TAVR Doc Survey
Tweet Send to a Friend
Piper Sandler analyst Adam Maeder raised the price target on Edwards Lifesciences (NYSE: EW) to $93.00 (from $91.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
